Use of Relaxin to Suppress Atrial Fibrillation

Description

Disclosed herein are methods of using relaxin polypeptides and analogs, or nucleic acid molecules encoding such polypeptides to treat or inhibit atrial fibrillation.

IP Status

https://patents.google.com/patent/US20220289809A1